Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study

Zhao-Ming Chen,Zheng-Tu Li,Shao-Qiang Li,Wei-Jie Guan,Ye Qiu,Zi-Ying Lei,Yang-Qing Zhan,Hua Zhou,Sheng Lin,Xinni Wang,Zhun Li,Feng Yang,Wen Zeng,Ye Lin,Jing Liu,Jian-Quan Zhang,Feng Ye
DOI: https://doi.org/10.1186/s12879-021-06255-9
IF: 3.7
2021-06-19
BMC Infectious Diseases
Abstract:Abstract Background Talaromyces marneffei ( T. marneffei) infection has been associated with adult-onset immunodeficiency due to anti-IFN-γ autoantibodies. We aimed to investigate the clinical features of non-HIV-infected patients with T. marneffei infection in southern China. Methods Between January 2018 and September 2020, we enrolled patients with T. marneffei infection who were HIV-negative (group TM, n = 42), including anti-IFN-γ autoantibody-positive (group TMP, n = 22) and anti-IFN-γ autoantibody-negative (group TMN, n = 20) patients and healthy controls (group HC, n = 40). Anti-IFN-γ autoantibodies were detected by ELISA. Clinical characteristics and clinical laboratory parameters were recorded. Results Compared with anti-IFN-γ autoantibody-negative patients with T. marneffei infection, anti-IFN-γ autoantibody-positive patients did not have underlying respiratory disease; more frequently exhibited dissemination of systemic infections with severe pleural effusion; had higher WBC counts, C-reactive protein levels, erythrocyte sedimentation rates, and neutrophil and CD8 + T cell counts; had lower hemoglobin levels; and were more likely to have other intracellular pathogen infections. Most of these patients had poor outcomes despite standardized antimicrobial therapy. Conclusion T. marneffei -infected patients with higher anti-IFN-γ autoantibody titers have more severe disease and complex clinical conditions.
infectious diseases
What problem does this paper attempt to address?